133
Views
24
CrossRef citations to date
0
Altmetric
Papers

Portuguese winemaking residues as a potential source of natural anti-adenoviral agents

, , , , , , , , & show all
Pages 357-368 | Received 20 Aug 2009, Accepted 21 Oct 2009, Published online: 29 Jan 2010
 

Abstract

To date there are no licensed systemic or topical treatments in Europe or the USA for adenovirus infections. In the present paper, we evaluate the effect of a polyphenol-based grape extract (NE) obtained from Portuguese white-winemaking by-products, and Resveratrol in pure form, on adenovirus type 5 infection. For this purpose, recombinant adenovirus vectors (Ad-5) and a human-derived cell line (293) were used as models. The NE and Resveratrol at the used concentrations do not induce cell cytotoxicity or direct virucidal activity; however, they reduce 4.5 and 6.5 log (TCID50/ml) on total infectious Ad-5 production, respectively. The capacity of Ad-5 replication upon removal of NE and Resveratrol after 24 h post infection was also evaluated. In contrast to Resveratrol, the highest evaluated NE concentration inhibits irreversibly the Ad-5 replication. These results provide useful information for the use of NE and Resveratrol as potential sources of promising natural antiviral agents on Ad-5 infection.

Acknowledgements

The authors are grateful to Rita Malpique from the Animal Cell Technology laboratory for providing technical support with antiviral assays.

Declaration of interest: Ana Matias is grateful to FC–MCES, Portugal and to Sovena–ComÉrcio e Indústria de Produtos Alimentares, S.A. for financial support, through grant SFRH/BDE/15535/2005. Ana Teresa Serra, Isabel Marcelino and Tiago B. Ferreira also acknowledge FCT–MCTES for financial support, through the grants SFRH/BD/19238/2004, SFRH/BD/14378/2003 and SFRH/BD/10614/2002, respectively.

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.